Tardive Dyskinesia Market Forecast Report: Key Players and Future Growth
Antipsychotic medications save lives — but for a meaningful share of patients, they also come with a hidden cost: involuntary, repetitive movements that can persist long after the drug is stopped. That's the clinical reality driving expansion of the tardive dyskinesia therapeutics market, which stood at roughly USD 4,400 million across the 7MM in 2025 and is on track to nearly double to...
0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen